# Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer

> **NCT03954756** · PHASE2 · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 35 (estimated)

## Conditions studied

- Advanced Gastric Cancer

## Interventions

- **DRUG:** Apatinib and PD1

## Key facts

- **NCT ID:** NCT03954756
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-01
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-06-01
- **Target enrollment:** 35 (ESTIMATED)
- **Last updated:** 2019-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954756, "Exploratory Clinical Study of Apatinib and PD-1 in Treating Advanced Gastric Cancer". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT03954756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*